Follow
Sunil Sharma
Sunil Sharma
Verified email at tgen.org
Title
Cited by
Cited by
Year
Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer
AT Shaw, DW Kim, R Mehra, DSW Tan, E Felip, LQM Chow, DR Camidge, ...
New England Journal of Medicine 370 (13), 1189-1197, 2014
18222014
Safety and efficacy of durvalumab (MEDI4736), an anti–programmed cell death ligand-1 immune checkpoint inhibitor, in patients with advanced urothelial bladder cancer
C Massard, MS Gordon, S Sharma, S Rafii, ZA Wainberg, J Luke, ...
Journal of Clinical Oncology 34 (26), 3119, 2016
8922016
NCCN guidelines insights: colon cancer, version 2.2018
AB Benson, AP Venook, MM Al-Hawary, L Cederquist, YJ Chen, ...
Journal of the National Comprehensive Cancer Network 16 (4), 359-369, 2018
8552018
Rectal cancer, version 2.2018, NCCN clinical practice guidelines in oncology
AB Benson, AP Venook, MM Al-Hawary, L Cederquist, YJ Chen, ...
Journal of the National Comprehensive Cancer Network 16 (7), 874-901, 2018
8502018
Colon cancer, version 1.2017, NCCN clinical practice guidelines in oncology
AB Benson, AP Venook, L Cederquist, E Chan, YJ Chen, HS Cooper, ...
Journal of the National Comprehensive Cancer Network 15 (3), 370-398, 2017
7552017
Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial
DW Kim, R Mehra, DSW Tan, E Felip, LQM Chow, DR Camidge, ...
The lancet oncology 17 (4), 452-463, 2016
5002016
Diet-induced obesity promotes depressive-like behaviour that is associated with neural adaptations in brain reward circuitry
S Sharma, S Fulton
International journal of obesity 37 (3), 382-389, 2013
4442013
International Nosocomial Infection Control Consortium report, data summary of 50 countries for 2010-2015: Device-associated module
VD Rosenthal, HM Al-Abdely, AA El-Kholy, SAA AlKhawaja, ...
American journal of infection control 44 (12), 1495-1504, 2016
4122016
International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module
VD Rosenthal, DG Maki, Y Mehta, H Leblebicioglu, ZA Memish, ...
American journal of infection control 42 (9), 942-956, 2014
4062014
A phase I study of intravenous LBH589, a novel cinnamic hydroxamic acid analogue histone deacetylase inhibitor, in patients with refractory hematologic malignancies
F Giles, T Fischer, J Cortes, G Garcia-Manero, J Beck, F Ravandi, ...
Clinical Cancer Research 12 (15), 4628-4635, 2006
3752006
Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells
W Fiskus, S Sharma, B Shah, BP Portier, SGT Devaraj, K Liu, SP Iyer, ...
Leukemia 28 (11), 2155-2164, 2014
2902014
Targeting Axl and Mer kinases in cancer
A Verma, SL Warner, H Vankayalapati, DJ Bearss, S Sharma
Molecular cancer therapeutics 10 (10), 1763-1773, 2011
2622011
Adaptations in brain reward circuitry underlie palatable food cravings and anxiety induced by high-fat diet withdrawal
S Sharma, MF Fernandes, S Fulton
International journal of obesity 37 (9), 1183-1191, 2013
2492013
Colon cancer, version 3.2014
AB Benson, AP Venook, T Bekaii-Saab, E Chan, YJ Chen, HS Cooper, ...
Journal of the National Comprehensive Cancer Network 12 (7), 1028-1059, 2014
2422014
Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1–3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations
SK Pal, JE Rosenberg, JH Hoffman-Censits, R Berger, DI Quinn, ...
Cancer discovery 8 (7), 812-821, 2018
2352018
A Phase Ib Dose-Escalation Study of Encorafenib and Cetuximab with or without Alpelisib in Metastatic BRAF-Mutant Colorectal Cancer
RMJM Van Geel, J Tabernero, E Elez, JC Bendell, A Spreafico, M Schuler, ...
Cancer discovery 7 (6), 610-619, 2017
2342017
Rectal cancer, version 2.2015
AB Benson, AP Venook, T Bekaii-Saab, E Chan, YJ Chen, HS Cooper, ...
Journal of the National Comprehensive Cancer Network 13 (6), 719-728, 2015
2312015
Rectal cancer
AB Benson, T Bekaii-Saab, E Chan, YJ Chen, MA Choti, HS Cooper, ...
Journal of the National Comprehensive Cancer Network 10 (12), 1528-1564, 2012
2132012
High-Throughput Virtual Screening Identifies Novel N′-(1-Phenylethylidene)-benzohydrazides as Potent, Specific, and Reversible LSD1 Inhibitors
V Sorna, ER Theisen, B Stephens, SL Warner, DJ Bearss, ...
Journal of medicinal chemistry 56 (23), 9496-9508, 2013
2032013
Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells
W Fiskus, S Sharma, J Qi, JA Valenta, LJ Schaub, B Shah, K Peth, ...
Molecular cancer therapeutics 13 (5), 1142-1154, 2014
2012014
The system can't perform the operation now. Try again later.
Articles 1–20